 Neuropathic pain, NEP, is a debilitating condition affecting approximately 1 million people in Canada. Guidelines for its pharmacological management have been established, but further research is needed to determine the most effective medication options. This article was authored by D. Moulin, A. J. Clark, I. Gilron, and others.